PubMed · 8233189
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
M F Hunter, C Essex, P Tuohy. 1993-10-27. Screening microtympanometry.. https://pubmed.ncbi.nlm.nih.gov/8233189/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The incidence of sensorineural hearing loss (SNHL) was investigated in 68 patients who reached chronic renal failure (CRF) in childhood with the aim of identifying possible risk factors. Tests were carried out by means of pure-tone and impedance audiometry. SNHL was found in 29% of patients on conservative treatment, 28% of patients on hemodialysis, and 47% after renal transplantation. Differences among groups were not significant. A significant correlation was found with the administration of ototoxic drugs (aminoglycosides and furosemide). We hypothesize that SNHL may be reduced in patients with CRF or on renal replacement therapy by strictly monitoring ototoxic therapy.
Eighty eight (88) beta-thalassemic patients undergoing regular transfusion- chelation therapy with desferrioxamine (DFO) were studied for ENT problems from 1988 to 1993, as DFO has been implicated for auditory neurotoxicity. The mean age of the patients was 9.66 +/- 3.1 years, their pre-transfusion haemoglobin level was 9 +/- 2 g/dl, serum ferritin level was 2065 +/- 898 ng/ml and the daily DFO dose was 50.7 +/- 9.5 mg/kg for 5 days/week. The ENT study included, ENT examination, pure tone audiometry, speech audiometry, tympanometry, tone decay test and ABR. During this 6-year study 24/88 (27%) patients developed bilateral or ipsilateral sensorineural hearing loss in high tone frequencies, sometimes exceeding 80 dB, which was attributed to DFO toxicity. Therefore, a reduction or temporary withdrawal of DFO followed. After this intervention 12/24 patients recovered almost completely, 7/24 remained stable and 5/24 presented aggravation of their hearing loss. This study confirms the DFO induced auditory neurotoxicity and the necessity of periodical audiology control of beta-thalassemic patients for prompt diagnosis and management of this complication.
The effect of physical exercise on both distortion product otoacoustic emissions (DPOAE), and on the temporary effects of noise on human cochlear function was examined. Changes in DPOAEs were compared to changes in behavioural thresholds and the possible relation between contralateral suppression of DPOAEs and susceptibility to noise exposure was investigated. Békésy audiometry, tympanometry and DPOAEs were measured in 8 subjects on 3 separate occasions: before and after noise exposure; before and after exercise at 60% of maximal oxygen uptake (VO2max); and before and after a combination of noise exposure and exercise, all of 10 min duration. Noise exposure was third-octave band noise of 102 dB SPL centered at 2 kHz. The magnitude of the effect of noise exposure on DPOAE amplitude averaged in the 2-4 kHz range was comparable but weakly correlated to the magnitude of the temporary threshold shift (TTS) measured as the change in Békésy threshold at 3 kHz. There was no effect of physical exercise without noise exposure on either the Békésy threshold or the DPOAE amplitude. Physical exercise significantly increased the noise-induced TTS and the effect of noise exposure on DPOAE amplitude. A positive correlation was found between the temporary effect of noise exposure and the contralateral suppression effect on DPOAE amplitude.